Literature DB >> 11821954

Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions.

Nicolas Wentzensen1, Ruediger Ridder, Ruediger Klaes, Svetlana Vinokurova, Ulrike Schaefer, Magnus von Knebel Doeberitz.   

Abstract

Persistent high risk type human papillomavirus (HR-HPVs) infections induce dysplasia or cancer of the anogenital tract, most notably of the uterine cervix. The viral genome usually persists and replicates as an episomal molecule in early dysplasia, whereas in advanced dysplasia or cervical cancer HPV genomes are frequently integrated into the chromosomal DNA of the host cell. Previous studies suggested that modification of critical cellular sequences by integration of HPV genomes might significantly contribute to the neoplastic transformation of anogenital epithelia (insertional mutagenesis). This prompted us to characterize the integration loci of high risk HPV genomes in a large set of genital lesions. We amplified E6/E7 oncogene transcripts derived from integrated HPV16 and HPV18 genomes and characterized in detail the co-transcribed cellular sequences of 64 primary genital lesions and five cervical cancer cell lines. Database analyses of the cellular parts of these fusion transcripts revealed 51 different integration loci, including 26 transcribed genes (14 known genes, 12 EST sequences with unknown gene function). Seventeen sequences showed similarity to repetitive elements, and 26 sequences did not show any database match other than genomic sequence. Chromosomal integration loci were distributed over almost all human chromosomes. Although we found HPV sequences integrated into cancer related genes and close to fragile sites, no preferential site or integration motif could be identified. These data demonstrate that target directed insertional mutagenesis might occur in few HPV-induced anogenital lesions, however, it is rather the exception than the rule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821954     DOI: 10.1038/sj.onc.1205104

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer.

Authors:  Clara Bodelon; Svetlana Vinokurova; Joshua N Sampson; Johan A den Boon; Joan L Walker; Mark A Horswill; Keegan Korthauer; Mark Schiffman; Mark E Sherman; Rosemary E Zuna; Jason Mitchell; Xijun Zhang; Joseph F Boland; Anil K Chaturvedi; S Terence Dunn; Michael A Newton; Paul Ahlquist; Sophia S Wang; Nicolas Wentzensen
Journal:  Carcinogenesis       Date:  2015-12-09       Impact factor: 4.944

2.  Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.

Authors:  J R Montealegre; E C Peckham-Gregory; D Marquez-Do; L Dillon; M Guillaud; K Adler-Storthz; M Follen; M E Scheurer
Journal:  Gynecol Oncol       Date:  2017-12-21       Impact factor: 5.482

3.  Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.

Authors:  Takashi Hatano; Daisuke Sano; Hideaki Takahashi; Hiroshi Hyakusoku; Yasuhiro Isono; Shoko Shimada; Kae Sawakuma; Kentaro Takada; Ritsuko Oikawa; Yoshiyuki Watanabe; Hiroyuki Yamamoto; Fumio Itoh; Jeffrey N Myers; Nobuhiko Oridate
Journal:  Int J Cancer       Date:  2017-01-09       Impact factor: 7.396

4.  Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.

Authors:  Michael J Lace; James R Anson; Jens P Klussmann; Dong Hong Wang; Elaine M Smith; Thomas H Haugen; Lubomir P Turek
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

Review 5.  [HPV-associated tonsillar cancer. An update].

Authors:  J P Klussmann; S Dinh; O Guntinas-Lichius; C Wittekindt; S Weissenborn; U Wieland; H P Dienes; T Hoffmann; E Smith; L Turek; E J M Speel; H J Pfister
Journal:  HNO       Date:  2004-03       Impact factor: 1.284

6.  Clonal selection for transcriptionally active viral oncogenes during progression to cancer.

Authors:  Brian A Van Tine; John C Kappes; N Sanjib Banerjee; Judith Knops; Lilin Lai; Renske D M Steenbergen; Chris L J M Meijer; Peter J F Snijders; Pamela Chatis; Thomas R Broker; Phillip T Moen; Louise T Chow
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 7.  Human papillomavirus infections: warts or cancer?

Authors:  Louise T Chow; Thomas R Broker
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

Review 8.  [Viral carcinogenesis of head and neck tumors].

Authors:  N Wentzensen; M von Knebel Doeberitz
Journal:  Pathologe       Date:  2004-02       Impact factor: 1.011

9.  Overexpression of STAT3 in HPV-mediated cervical cancer in a north Indian population.

Authors:  R C Sobti; Neha Singh; Showket Hussain; Vanita Suri; A C Bharti; B C Das
Journal:  Mol Cell Biochem       Date:  2009-05-07       Impact factor: 3.396

10.  Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses.

Authors:  Ruprecht Kuner; Markus Vogt; Holger Sultmann; Andreas Buness; Susanne Dymalla; Julia Bulkescher; Mark Fellmann; Karin Butz; Annemarie Poustka; Felix Hoppe-Seyler
Journal:  J Mol Med (Berl)       Date:  2007-06-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.